Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Új-Zéland
4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Where
- Auckland
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05139017 · EU 2022-502646-27-00 - 2. fázisTaking peopleA Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma
- Where
- Auckland, Christchurch, Newtown
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Malaghan Institute of Medical Research
See details and how to joinNCT06486051 - 3. fázisTaking peopleA Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
- Where
- Grafton, Wellington
- Életkor
- 75 év and over
- People
- 300 worldwide
- Run by
- Nordic Lymphoma Group
See details and how to joinNCT04332822 · EU 2022-502887-19-00 - 2. fázisTaking peopleDPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Where
- Auckland, Palmerston North
- Életkor
- 18 év and over
- People
- 102 worldwide
- Run by
- ImmunoVaccine Technologies, Inc. (IMV Inc.)
See details and how to joinNCT04920617